We would love to hear your thoughts about our site and services, please take our survey here.
To be fair MM subsequently wrote:
'Hi Jake, thanks for highlighting - I should have written, "in my opinion / view".
Fortunately, it was out of market hours, so hopefully I won't get accused of pumping #AVCT! ??
Simba, you MUST know the answer to you own question, you've been invested here + 20 years. Per your April comment:
' rarely post here, been investing for over 20 yrs, i totally agree with your post, there are quite a few areas in the diagnostics and therapeutics that will push up the SP when good news arrives, as a long term holder, be patient, this a great company and will reward us all IMHO'
So right rxdav. Aldebaran's post 1 march:
"This is going 20p beenn saying, for long enough. Rampers get all excited other day gor nowt. As it gets closer to that price it will get more obvious just remember those of us who called it at 70p plus"
Suggests he anticipates 'surfing'.
For anyone (like me) who doesn't know what a 'poster presentation' is here is a link to the appropriate AACR webpage
https://www.aacr.org/patients-caregivers/patient-advocacy/education-inspiration/how-to-series/tips-to-interpret-a-scientific-poster/
Most of 'those people' probably had stop losses executed. Let's face it, who on this BB (or anywhere else) managed to sell above £1. So, why would they jump into another stock with a similar sp history.....unless they have an addiction, & are way in over their heads financially.
Tfawcett, purely for info:
https://www.sciencedirect.com/science/article/abs/pii/S0165993619305412
Monkshood, no doubt you're right & the the Company's focus is therapeutics. However, they do have a track record with diagnostics prior to covid, with Zika. I felt that went nowhere due lack of interest from potential development partners. Covid changed all that, & the chance to bring an accurate diagnostic to market was an opportunity not to be missed. You query re S & N is interesting, & must be worth a question at the next 'investormeet'
ODX today
"This new legislation is not expected to cause a delay in the supply of Omega's VISITECT® professional-use COVID-19 Antigen test to DAM Health clinics in the UK under the agreement announced on 1 November 2021. Omega currently remains free to supply LFTs to DAM Health's clinics throughout Europe and DAM Health are able to distribute Omega's LFT throughout Europe."
ODX today
"This new legislation is not expected to cause a delay in the supply of Omega's VISITECT® professional-use COVID-19 Antigen test to DAM Health clinics in the UK under the agreement announced on 1 November 2021. Omega currently remains free to supply LFTs to DAM Health's clinics throughout Europe and DAM Health are able to distribute Omega's LFT throughout Europe."